BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Daiichi Sankyo
US Army

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074558

« Back to Dashboard

NDA 074558 describes CHOLESTYRAMINE LIGHT, which is a drug marketed by Par Pharm, Sandoz, Teva, Teva Pharms, and Zydus Pharms Usa Inc, and is included in five NDAs. It is available from five suppliers. Additional details are available on the CHOLESTYRAMINE LIGHT profile page.

The generic ingredient in CHOLESTYRAMINE LIGHT is cholestyramine. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.

Summary for 074558

Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074558

Mechanism of ActionBile-acid Binding Activity

Suppliers and Packaging for NDA: 074558

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074558 ANDA Eon Labs, Inc. 0185-0939 0185-0939-98 60 POUCH in 1 CARTON (0185-0939-98) > 5.7 g in 1 POUCH
CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074558 ANDA Eon Labs, Inc. 0185-0939 0185-0939-97 239.4 g in 1 CAN (0185-0939-97)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/PACKET
Approval Date:Aug 15, 1996TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/SCOOPFUL
Approval Date:Aug 15, 1996TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: